Ten63 Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives

Board Members

Investors

Total Funding

$21.3M

Investors

12 investors across all rounds

Alexandria Venture Investments

Calm Ventures

Duke Capital Partners

VENTURE_CAPITAL

+7 more investors

Explore More Data

Detailed analysis for Ten63 Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Ten63 Therapeutics Leadership & Investors

Ten63 Therapeutics is led by a team of experienced leaders. The company has attracted investment from 12 institutional and strategic investors.

Who Has Invested in Ten63 Therapeutics?

Ten63 Therapeutics has raised $21.3M from 12 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Ten63 Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.